// App-Quantinova.ai

BSH19‐OR‐002 : Validating Whole Genome Sequencing (WGS) for clinical use in AML & ALL

Researchers

Presenter

  • S. Henderson

Principal Investigators

  • A. Sosinsky

  • A. Hamblin

  • J. Ambrose

  • A. Rueda-Martin

  • D. Perez-Gil

  • C. Aguilera

  • J. Chalker

  • E. Hodges

  • C. Turnbull

  • N. Murugaesu

  • L. Jones

  • T. Fowler

  • Z. Deans

  • A. Rendon

  • S. Hill

  • M. Caulfield

Medical Centers

  • Genomics England, Queen Marys, London University

  • Great Ormond Street Hospital, London, Italy

  • University of Southampton, Southampton, UK

  • Genomics Implementation Unit, NHS England, Skipton House, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Breakpoint Cluster Region

  • ETV6-RUNX1

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved